| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $701.2M | +1.9% |
| Cost of Revenue | $347.3M | +13.3% |
| Gross Profit | $353.9M | -7.2% |
| R&D Expense | $23.3M | -11.1% |
| SG&A Expense | $315.6M | -0.9% |
| Operating Income | -$61.6M | +84.5% |
| Pre-tax Income | -$66.2M | +83.6% |
| Income Tax | $6.7M | +139.4% |
| Net Income | -$72.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $89.8M | -16.6% |
| Accounts Receivable | $103.8M | -21.8% |
| Inventory | $148.0M | +6.6% |
| Current Assets | $355.4M | -9.7% |
| Total Assets | $1.07B | -7.0% |
| Current Liabilities | $165.2M | -0.4% |
| Long-term Debt | $90.3M | -27.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $74.7M | -25.8% |
| Investing Cash Flow | -$60.6M | -120.4% |
| Financing Cash Flow | -$37.0M | +24.6% |
| +81.4% |
| EPS (Basic) | -$1.57 | +81.6% |
| EPS (Diluted) | -$1.57 | +81.6% |
| Total Liabilities |
| $295.5M |
| -9.3% |
| Stockholders' Equity | $778.2M | -6.1% |